SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GMAB

Genmab A/S (NASDAQ:GMAB)

DK · Delayed Price · Currency is USD
Healthcare · Biotechnology
57.29+12.62 (+28.25%)
 
Market cap
$35.2B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 1, 2009
Website
Insider Score
––Not scored
GMAB Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

Congress Trading

Recent trades of GMAB by members of U.S. Congress

PoliticianTypeTraded
Alan ArmstrongSenate / RPurchase$1.00K – $15.00KMar 30, 2026
Josh GottheimerHouse / DPurchase$1.00K – $15.00KJan 16, 2025
Josh GottheimerHouse / DSale$1.00K – $15.00KDec 16, 2024
Josh GottheimerHouse / DPurchase$1.00K – $15.00KJul 19, 2024
Josh GottheimerHouse / DSale$1.00K – $15.00KJun 18, 2024
Josh GottheimerHouse / DPurchase$1.00K – $15.00KOct 16, 2023
Josh GottheimerHouse / DSale$1.00K – $15.00KSep 15, 2023
Josh GottheimerHouse / DPurchase$1.00K – $15.00KJul 20, 2023

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

GMAB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New GMAB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to GMAB from public contracts

Source: USAspending.gov

Recently reported changes in GMAB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing GMAB, reported under the STOCK Act.

PoliticianChamberActionAmountDate
SenateBuy$1.00K – $15.00KMar 30, 2026
HouseBuy$1.00K – $15.00KJan 16, 2025
HouseSell$1.00K – $15.00KDec 16, 2024
HouseBuy$1.00K – $15.00KJul 19, 2024
HouseSell$1.00K – $15.00KJun 18, 2024
HouseBuy$1.00K – $15.00KOct 16, 2023
HouseSell$1.00K – $15.00KSep 15, 2023
HouseBuy$1.00K – $15.00KJul 20, 2023
HouseBuy$1.00K – $15.00KJul 19, 2023
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Genmab A/S (GMAB) Government Contracts & Lobbying | InsiderBuying.com